Balentine LLC’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,206
| Closed | -$228K | – | 609 |
|
|
2022
Q4 | $228K | Sell |
2,206
-212
| -9% | -$21.9K | 0.01% | 503 |
|
|
2022
Q3 | $205K | Sell |
2,418
-296
| -11% | -$25.1K | 0.01% | 483 |
|
|
2022
Q2 | $225K | Buy |
+2,714
| New | +$225K | 0.01% | 506 |
|
|
2020
Q3 | – | Sell |
-28
| Closed | -$3K | – | 236 |
|
|
2020
Q2 | $3K | Sell |
28
-248
| -90% | -$26.6K | ﹤0.01% | 786 |
|
|
2020
Q1 | $23K | Buy |
+276
| New | +$23K | ﹤0.01% | 254 |
|
|
2019
Q4 | – | Sell |
-37
| Closed | -$2K | – | 616 |
|
|
2019
Q3 | $2K | Buy |
+37
| New | +$2K | ﹤0.01% | 631 |
|
|
2018
Q1 | – | Sell |
-42
| Closed | -$4K | – | 120 |
|
|
2017
Q4 | $4K | Sell |
42
-45
| -52% | -$4.29K | ﹤0.01% | 531 |
|
|
2017
Q3 | $8K | Hold |
87
| – | – | ﹤0.01% | 482 |
|
|
2017
Q2 | $8K | Hold |
87
| – | – | ﹤0.01% | 459 |
|
|
2017
Q1 | $8K | Buy |
87
+42
| +93% | +$3.86K | ﹤0.01% | 432 |
|
|
2016
Q4 | $4K | Buy |
45
+10
| +29% | +$889 | ﹤0.01% | 455 |
|
|
2016
Q3 | $3K | Hold |
35
| – | – | ﹤0.01% | 421 |
|
|
2016
Q2 | $3K | Hold |
35
| – | – | ﹤0.01% | 414 |
|
|
2016
Q1 | $3K | Hold |
35
| – | – | ﹤0.01% | 308 |
|
|
2015
Q4 | $4K | Buy |
35
+8
| +30% | +$914 | ﹤0.01% | 390 |
|
|
2015
Q3 | $3K | Buy |
+27
| New | +$3K | ﹤0.01% | 432 |
|